Chimera Investment Corporation (CIM) Earnings Call Transcript & Summary
February 17, 2022
Earnings Call Speaker Segments
Victor Falvo
executiveThanks, Ashley, and I appreciate all of you joining us for Chimera's call covering the fourth quarter and the full year 2021 results. Ahead of getting started, let me walk through the Safe Harbor statements. On this call, forward-looking statements will be made, meaning predictions, projections, or other statements regarding future events. Such statements rest on current expectations and assumptions that carry risks and uncertainties, all of which are described in the Risk Factors section found in our latest annual and quarterly SEC filings. Actual events and results could differ materially from those forward-looking statements. We urge you to review the forward-looking statement disclaimer included in our earnings release, along with our quarterly and annual filings. Also, on today's call, non-GAAP financial measures may be discussed. For reconciliation to the most comparable GAAP measures, please see our SEC filings and earnings supplement. In addition, what is said on this conference call could include time-sensitive information that is accurate only as of today's earnings call date. No undertaking is made, and any obligation to update or revise this information is specifically disclaimed. I'll now hand the conference over to Mohit Marria, our CEO and Chief Investment Officer.
Mohit Marria
executiveThank you, Vic. Greetings, everyone, and thanks for joining the fourth-quarter and full-year 2021 earnings call for Chimera Investment Corporation. Joining me on this call are our President and Chief Operating Officer, Choudhary Yarlagadda; our Chief Financial Officer, Subra Viswanathan; and our Head of Capital Markets, Vic Falvo. Once I've finished my remarks, Subra will walk through the financial results, and following that, we'll take your questions. For the better part of 2021, interest rates stayed low, and investors showed strong demand for high quality fixed income assets, which allowed Chimera to fine-tune the structure of its liabilities — a move we believe will benefit shareholders over the long run. Securitizing mortgage assets sits at the heart of this company's DNA and is essential to how Chimera stands apart from peers in the market. By using innovative structuring methods, we've shown again and again that we can handle asset and liability risk in our portfolio efficiently while keeping recourse leverage low and net interest spreads attractive. On the reperforming loans bought between 2016 and 2018, portfolio yields came in above what we had initially expected. Thanks to our re-securitization work in 2021, we were able to refinance the debt tied to those loans at a reduced interest expense and also unlock equity from the initial purchases. During 2021 as a whole, eight fresh securitizations were used to refinance thirteen reperforming deals issued earlier, and those transactions encompassed $6 billion in mortgage loans. Thanks to Chimera's re-securitization efforts last year, the improved advance rates unlocked over $900 million in capital, which helped us fulfill a variety of objectives designed to strengthen our balance sheet. Because interest costs came down and advance rates on the securitizations we completed in 2021 were better, our asset and liability structure now enjoys a meaningful edge; it boosted the yields on the investments we newly retained and allowed us to shift additional financing from recourse to non-recourse, an unmistakable long-term gain. Our 2021 efforts cut recourse financing on credit assets by more than $800 million while bringing down interest expense on our credit-related repo considerably; on top of that, we paid off $400 million of high-cost debt along with the related warrants and retired the last $50 million of convertible debt. All told, securitized debt makes up 70% of total financing, compared with 65% in 2020. At year-end, our cost of securitized debt stood at 2.40%, which is 120 basis points lower than 2020. A fixed rate coupon applies to 98% of our securitized debt, and that matters now that interest rates have started climbing. Because the rates we secured are fixed, we're able to keep a broad net interest spread on securitized assets locked in for a long stretch. Most of the securitizations we structure carry explicit call dates. In 2021 we exercised calls on 13 deals, 14 more can be called during 2022, and the weighted average time until call across our full stack of securitized debt comes to three years. These call dates give us the ability to reshape our funding structure frequently, which has proven incredibly useful. Now I'd like to take you through our activity on the asset purchase side and in securitizations for the fourth quarter. In Q4, we acquired $540 million of reperforming loans. We closed on $100 million of those loans in December, and we anticipate that $440 million of them will close during the first quarter of 2022. Across all of 2021, we acquired more than $3.2 billion in loans: $1.3 billion of reperforming loans, $320 million of business purpose loans, $1.2 billion of prime jumbo loans, and $435 million of agency eligible investor loans. Turning to securitization activity, in October we securitized $354 million CIM 2021-R6 using reperforming loans from our loan warehouse. We sold $336 million in notes, which works out to a 95% advance rate — the best advance rate we have ever gotten on reperforming loans. For the R6 deal, the average cost of debt is 1.53%. Chimera retained a stake of $18 million, made up of subordinate notes plus interest-only securities. The R6 transaction received ratings from Fitch and DBRS, and beginning in September 2026 it can be called. November brought the completion of our fourteenth—and final—securitization for that year: CIM 2021-NR4, a $168 million offering collateralized by non-performing loans held in our warehouse. Senior securities totaling $126 million were sold, representing 75% of the capital structure. As an investment, we held onto $42 million of subordinate notes. No other year in Chimera's history saw as much securitization activity as 2021. In total, across 14 distinct securitized deals, Chimera sponsored $8 billion: six securitizations of reperforming loans, four involving non-performing loans, three backed by prime jumbo loans, and one securitization of agency eligible investor loans. On our balance sheet, we've brought together the reperforming and non-performing deals through consolidation. The prime jumbo and agency-eligible loans, however, are not consolidated there. Going into 2022, we're positioned well for today's market, where rates are higher and spreads are wider. With 95% of capital devoted to residential mortgage credit, our balance sheet is solid. Securitized debt makes up 70% of our financing, and we see this as providing the best long-term, non-recourse funding for our loan portfolio. Our net interest spread is solid, mainly due to financing costs declining over the past year, and our leverage is at historically low levels; this year has brought significant accomplishments. Strong performance continues in our securitization business. Our cash position is strong enough to keep expanding the portfolio. Looking ahead into 2022, we remain committed to providing shareholders with the most attractive dividend available on a risk-adjusted basis. At this point, I'll hand things over to Subra, who will walk through the financial results.
Subra Viswanathan
executiveThanks, Mohit. I'll go over Chimera's financial highlights covering both the fourth quarter and the entire 2021 fiscal year. GAAP book value closed the quarter at $11.84 per share, while our economic return on book value came in at -1.2%, calculated from the quarterly shift in book value plus the fourth quarter's common stock dividend. For the full year, that figure was 6.2%. The fourth quarter dividend amounted to $0.78. For the entire year, GAAP net income came to $596 million, equal to $2.44 per share. On an Earnings available for distribution basis, Q4 net income reached $111 million, or $0.46 per share, while the full year totaled $4.00 per share. As for one-time non-recurring items, we booked about $0.08 of income from securities called during the quarter, along with $0.26 of income from securities. That said, we don't expect income of this size every quarter, though it can happen from time to time; in some quarters, a loss related to interest-only securities being called is possible. Any time such income becomes material to our Earnings available for distribution, we'll provide the details. Economic net interest income in Q4 reached $155 million, and for the full year it was $613 million. During the fourth quarter, average interest earning assets yielded 2.3%, while our net interest spread came in at 4.1%. Total leverage stood at X to one, and recourse leverage stood at Y to one. Return on average equity was 18.1%. Finally, our 2021 full-year expenses, once servicing fees and transaction expenses are excluded, totaled $69.1 million, consistent with the prior year; that brings my remarks to a close. We are now ready to take questions.
Mike Smyth
analystHi, everybody. It's Mike Smyth here, filling in for Bose. To kick things off, during your prepared comments you brought up the latest RPL transaction and its 95% advance rate. I'd like to ask about that deal, and also whether you'd ever carry repo against it too, or whether the subordinate fees give you an unlevered ROE that's high enough?
Mohit Marria
executiveHi, Mike, it's Mohit. How's it going? Regarding the 2021 R6 transaction, like we said in the opening remarks, we kept an $18 million investment. On top of that, the derivatives that got created, along with the returns from the sub stack and the IOs, are going to generate yields in the very high single digits to low double digits. Based on what kind of financing we're able to obtain for the sub stack, there's a possibility we could repo it. Right now, as we've pointed out on earlier calls, it comes down to how the retained pieces are financed. Our preference leans toward non-mark-to-market with a longer tenor, so maybe we could add that down the road.
Mike Smyth
analystGreat. That's useful color. We've been hearing that volatility has ticked up somewhat in the securitization markets these past few weeks. I'd just like to get your take on that, and how long you think any volatility will last.
Mohit Marria
executiveYeah. I mean, we've witnessed an uptick previously. Typically the GSE effect of drawing buyers in has, but deal flow has clearly been elevated. Much of the volatility sits on the prime jumbo and non-QM side. Seasoned reperforming securitizations are scarce, even during last year, apart from us and a small number of other issuers. Again, I believe the macro rate volatility event caused the big wave of deal volume during the first six weeks, and that has also pressured spreads in the near term. Our view is it will stabilize, given housing is still strong and yields on these assets, on these new deals that weren't available a year ago, remain an attractive place to put money, so we stay optimistic. As we said in the opening remarks, 14 deals are callable across the year, and we'll watch how the market looks as we look to take advantage of that, the way we did last year.
Mike Smyth
analystGreat. That's helpful; then as a follow-up, have you noticed any movement in loan prices that reflects the wider spreads in the securitization market?
Mohit Marria
executiveLoan pricing has stayed more sticky than where execution is happening on the new issue space. Again, the translation on the new issue side, whether that's prime jumbo, agency eligible investor or non-QM spread widening there on the loan front. Again, in the RPL space, the primary sellers there are still the GSEs. Certain funds are going to wind down. For the portion of this year we've observed thus far, spreads have widened slightly, though not to any meaningful degree, which contrasts with what's happening in prime jumbo and non-QM.
Mike Smyth
analystThat's useful. I appreciate you fielding the questions.
Mohit Marria
executiveThanks, Mike.
Eric Hagen
analystHi, thanks. Morning to everyone. I might have a few here. Regarding that $108 million of unrealized losses during the period, could you shed some light on the source of those marks? And clearly you brought up the callable securitized debt. Could you discuss how you weigh the possibility of increased funding expenses when those transactions reach their call dates against the capacity to achieve greater leverage and rework your advance rate and similar items? Thanks.
Mohit Marria
executiveAbsolutely. Eric, the latter portion I'll address first, and Subra is able to provide insight on the earlier portion concerning unrealized losses stemming from fair value adjustments. You see, the trade-off — or I should say the economics — when evaluating whether to call a deal or leave it alone come down to two factors, and you named both of them. First is whether the total financing cost declines. Second is whether the structural leverage falls short of optimal, and a call would let us improve it and pull out some equity. Those are the two considerations we examine whenever we decide on a call. During calendar year 2021, we were fortunate to accomplish both — cutting financing costs by a considerable amount while simultaneously reaching a greater advance rate, which produced an equity release exceeding $900 million. If you review the transactions listed in the supplement on its final page, those 14 deals have performed very well. Without question, given the robust securitization market and strong housing conditions, we ought to be able to secure an advance rate comparable to what we achieved on the securitizations completed in 2021. That covers the first factor. Considering when those transactions were completed — going back to 2018 and 2019 — rates were clearly above where they stand now; for certain ones, a cost reduction might still be available, yet the capacity to extract equity while rates rise and spreads widen should still allow us to benefit from putting fresh capital to work in new assets. With any luck, that addresses what you asked. As for fair value, I'll have Subra address that along with how it breaks down.
Subra Viswanathan
executiveThank you, Mo. On the securitized loans, we experienced a decline, or unrealized losses. For the Non-Agency senior securities positions, and for the securitized debt — which represented our liabilities — we recorded a drop of 114 basis points. That is how it breaks down.
Eric Hagen
analystYeah, many of our older holdings have clearly been refinanced, and the rate movement during Q4 was more concentrated early on, especially for the 10-year. You know, that shift in rates caused certain legacy assets of ours to be priced lower still. That's useful. Regarding the securitized debt that can be called this year, could you tell us what the fixed rate coupon on that debt is?
Mohit Marria
executiveThat figure isn't available with me right now, but we can obtain it for you folks. I believe it ought to be in the financial-
Eric Hagen
analystYeah. All right. Thanks a lot. I appreciate that.
Kenneth Lee
analystHi. Thank you for taking my question. You mentioned this in passing, but I was just curious if you could expand a bit more on what returns you anticipate from the resi mortgage loans under today's conditions. Thanks.
Mohit Marria
executiveSure. Hey, Ken. You know, when it comes to levered returns on what we originated, they are, you know, in the low double digits when adjusted for losses. That suggests some leverage, and depending on the structure it takes, high double digits, you know, somewhere between 17%-18%, again depending on the leverage you incorporate into those. Looking ahead, you know, there's clearly been additional volatility in the new issue market, I suppose mainly within prime jumbo and non-QM; that ought to also create pressure on loan pricing, even though it hasn't shown up yet. We believe, you know, those two factors should shift together and your returns on retained pieces even this year ought to generate, you know, fairly appealing risk-adjusted returns within the same framework as last year.
Kenneth Lee
analystGotcha. Very helpful. One follow-up, if I may. Given today's conditions and clearly, the macro environment, how would you describe your present investment posture? Put differently, do you anticipate levels or might you get somewhat more appealing potentially? Thanks.
Mohit Marria
executiveYeah. No, that's a solid question, Ken. Thank you. You know, as we planned last year, we adopted a defensive approach just, you know, because of the uncertainty, you know, the pandemic and how long it might persist. We still had a highly successful year in achieving and purchasing a $3.2 billion portfolio. As we sit here with, you know, 0.9x recourse leverage and plenty of liquidity available to us, we actually intend to go on the offensive here, whether that's on the agency side, given the spread widening and greater clarity from the Fed unwinding or reducing their, you know, activity. You know what's occurring in the new issue market, which ought to result in some widening on loan spreads. I think we are actually very well positioned to seize all of those investment opportunities that might become available. I think we will aim to raise leverage from where we are at 0.9 higher here.
Kenneth Lee
analystGreat. Very helpful. Thanks.
Mohit Marria
executiveThank you, Ken.
Trevor Cranston
analystHey, thanks. Morning. You all brought up the kind of pricing shift you've observed mainly in prime jumbo and non-QM during Q4 and Q1. Could you likewise address any shifts you've noticed regarding the availability of loan products, considering the volatility in Q1, and what you anticipate for that element going forward?
Mohit Marria
executiveAbsolutely, Trevor. I'll handle this one. When it comes to prime jumbo and non-QM, from the perspective of an originator, I believe we'll watch them keep churning — so to speak — their origination channels built on this infrastructure. I believe we'll have plenty of chances to purchase however much of that product we desire. I don't believe, you know, to the degree that we completed 4 securitizations total on new issue on agency eligible investor. On the RPL side, as I mentioned, much of that flow is mainly originating from the GSEs. There are $12 billion-$18 billion in loan sales annually. We'll see how their 2022 calendar shapes up. We did receive the initial announcement from Fannie Mae. We believe once more that supply will be more governed by, you know, the GSEs. We'll keep that market, at least from a spread standpoint, more governed than us simply bringing deals to market too, you know, and considering how much rates have shifted in the first 6 weeks of this year.
Trevor Cranston
analystSo then, you know, considering how large the rate movement has been, plus some credit spread widening witnessed in Q1, do you all have any estimate for how your book values have shifted since year-end?
Mohit Marria
executiveI believe our approximate book value change since the beginning of the year is.
Trevor Cranston
analystUp 2.5%. Sorry. Down 2.5%. Okay. Understood.
Mohit Marria
executiveRoughly down 2.5%.
Trevor Cranston
analystRight.
Doug Harter
analystJust, Mohit, as you examine the opportunity set, you know, could you discuss the relative appeal of legacy compared with agency and, you know, how, you know, as you aim to become somewhat more offensive as you mentioned, allocate among those opportunity sets?
Mohit Marria
executiveCertainly. You know, I'm presuming when you refer to legacy securities.
Doug Harter
analystNaturally.
Mohit Marria
executiveRegarding loans, I think once again, given the rate environment we're in, convexity will matter more this year than in previous years. Holding 170-month seasoned loans and understanding how they'll prepay and perform will be far more informative. That stays a major focus for us. You know, we managed to add $1.2 billion of those loans last year; we're hopeful that from the GSEs this year we'll achieve greater success. When it comes to new originations, I'd say there are opportunities for us to add loans there too. Yet much of that depends on where securitization exits land for those loan purchases, along with how the retained portions end up looking. Our choices will keep being guided by that, just as they always have been. Clearly, certain loan-level tweaks the GSEs put in place as this year began mean a bigger private label exit for a number of these originators. For us to capitalize on that, we simply require the market to settle down on the new issue side and on the securitization side. You know, looking more broadly, take the agency space, where we've truly had no agencies going back to March of 2020. Since the Fed announcement, we've witnessed the basis widen by 25 to 30 basis points thus far. You know, our view is those could stretch out somewhat further. Once more, from our standpoint, the all-in yields you can get right now are likely around the levels we last saw in 2019 for relative value to make sense across this year, and we'll seize those opportunities.
Doug Harter
analystGreat. That's helpful. Thank you, Mohit.
Mohit Marria
executiveThanks, Doug.
Mohit Marria
executiveThank you, Ashley. Thanks everyone for joining us today. We look forward to speaking to you on our Q1 call.
Operator
operatorThanks a lot. That brings today's program to a close. We appreciate everyone taking part. You're free to drop off whenever you'd like.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Chimera Investment Corporation transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →For developers and AI pipelines
Programmatic access to Chimera Investment Corporation earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Chimera Investment Corporation or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.